Evidence map›Paper›PMID 33950665›Full record

ArticleACS chemical neuroscience2021

Maria Plesia, Oliver A Stevens, Gavin R Lloyd, Catherine A Kendall, Ian Coldicott, Aneurin J Kennerley, Gaynor Miller, Pamela J Shaw, Richard J Mead, John C C Day and 1 more

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Maria PlesiaSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK.
Oliver A StevensInterface Analysis Centre, School of Physics, University of Bristol, Bristol BS8 1TL, UK.
Gavin R LloydPhenome Centre Birmingham, University of Birmingham, Birmingham B15 2TT, UK.
Catherine A KendallBiophotonics Research Unit, Gloucestershire Hospitals NHS Foundation Trust, Gloucester GL1 3NN, UK.
Ian ColdicottSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK.
Aneurin J KennerleyDepartment of Chemistry, University of York, York YO10 5DD, UK.
Gaynor MillerDepartment of Oncology and Metabolism, University of Sheffield, Sheffield S10 2RX, UK.
Pamela J ShawSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK.
Richard J MeadSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK.
John C C DayInterface Analysis Centre, School of Physics, University of Bristol, Bristol BS8 1TL, UK.
James J P AlixSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK.ORCID 0000-0001-8391-9749
University of Sheffield · GBGloucestershire Hospitals NHS Foundation Trust · GBUniversity of Bristol · GBUniversity of York · GB

Funding

Medical Research Council MC_PC_15034Medical Research Council MR/M009157/1
6 · The paper itself

Abstract

Neuromuscular diseases result in muscle weakness, disability, and, in many instances, death. Preclinical models form the bedrock of research into these disorders, and the development of

Indexed as

Amyotrophic Lateral SclerosisMuscular Dystrophy, DuchenneAnimalsDisease Models, AnimalHumansMiceMice, Inbred mdxMusclesMuscle, SkeletalSpectrum Analysis, RamanAmyotrophic lateral sclerosisbiomarkerDuchenne muscular dystrophymuscleRaman spectroscopy

Identifiers

PMID33950665
PMCPMC8154326
OpenAlexW3157577325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.